Skip to main content
. 2017 May 10;2017(5):CD006185. doi: 10.1002/14651858.CD006185.pub4

Peurala 2009.

Methods RCT
 Method of randomisation: sealed envelopes (stratified according to ability to walk)
 Blinding of outcome assessors: no
 Adverse events: 2 in treatment group A, 3 in control group
 Deaths: 1 in control group
 Dropouts: 5 in treatment group A, 1 in treatment group B, 3 in control group
 ITT analysis: not stated
Participants Country: Finland
 56 participants (22 in treatment group A, 21 in treatment group B, 13 in control group)
 Non‐ambulatory at start of study
 Mean age: 68 years
 Inclusion criteria: first supratentorial stroke or no significant disturbance from an earlier stroke (Modified Rankin Scale 0 to 2), acute phase after stroke with a maximum duration of 10 days, FAC 0 to 3, voluntary movement in the leg of the affected side, Barthel Index 25 to 75 points, age 18 to 85 years, no unstable cardiovascular disease, body mass index < 32, no severe malposition of joints, no severe cognitive or communicative disorders
 Exclusion criteria: not stated
Interventions Between June 2003 and December 2004, random allocation to 2 arms took place (2 walking exercise groups)
  • Gait training with Gait Trainer device (GT‐Group)

  • Overground walking training (WALK‐Group)


All participants received 55 minutes daily gait‐oriented physiotherapy and additional gait training for 15 sessions over 3 weeks (each session lasting maximum of 20 minutes of walking).
Between January 2005 and February 2007, random allocation to 3 arms took place (3 walking exercise groups)
  • Gait training with Gait Trainer device (GT‐Group)

  • Overground walking training (WALK‐Group)

  • Control group (CT‐Group)


All participants received 55 minutes daily gait‐oriented physiotherapy and additional gait training for 15 sessions over 3 weeks (each session lasting maximum of 20 minutes of walking). However, CT‐Group received 1 or 2 physiotherapy sessions daily but not at the same intensity as in the other groups.
Outcomes Outcomes were recorded at baseline and after 3 weeks and 6 months:
  • FAC

  • 10‐metre walk test

  • 6‐minute walk test

  • Modified Motor Assessment Scale

  • Rivermead Motor Assessment Scale

  • Rivermead Mobility Index

Notes Because we were interested in the effects of automated electromechanical‐ and robotic‐assisted gait‐training devices for improving walking after stroke, we combined the results of the CT‐Group and the WALK‐Group as one group, which we compared with the results from the GT‐Group.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk An investigator not involved in the study randomly assigned participants to groups using concealed envelopes.
Allocation concealment (selection bias) Low risk Allocation was performed by an independent person not otherwise involved with the participants.
Blinding of outcome assessment (detection bias) 
 All outcomes High risk No
Incomplete outcome data (attrition bias) 
 All outcomes Unclear risk Unclear whether reasons for missing outcome data are unlikely to be related to true outcome